Why Do People Believe Drugs Are Too Expensive?
We have long heard from the media that the pharmaceutical industry “over charges” for prescription drugs and “makes money at the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Old Weapons with A New Purpose – Using Antitrust Laws to Control Drug…
U.S. Antitrust laws traditionally have been used to address, manage, and deter companies from engaging in anti- competitive…
CMS Scraps Part B Demo
On Thursday, December 15, 2016, the Centers for Medicare & Medicaid Services decided not to go forward with the agency’s…
The Uncertain Future of Biosimilars in the United States
Friends of Cancer Research held an event, “The Future of the U.S. Biosimilars Market: Development, Education, and Utilization,” on…
Omnicare’s Unwanted Spotlight Produces Mixed Results
Omnicare has been in the news for two separate cases recently, one involving a whistleblower suit, and another involving Abbott…
Twenty State Attorneys General Sue Pharma Companies for Alleged Conspiracy
Twenty states have announced that they have filed a lawsuit against generic-drug makers including Heritage Pharmaceuticals Inc.,…
Has Integrity Become a Commodity? – Warning Signs of Bad Behavior for…
This article takes a fresh look at trends in changing norms of ethical behavior by senior management and the challenge for…
Updated Medicare and Medicaid Drug Spending Data Released
On November 15, 2016, the Centers for Medicare and Medicaid Services (CMS) released updated Medicare and Medicaid drug spending…
AHR Holds Congressional Briefing Focused on Cost Growth
The Alliance for Health Reform recently held a Congressional briefing about cost growth of pharmaceuticals in the Medicare program…
Medical Affairs and Marketing: The Evolving Role of the Compliance Officer
Historically, medical affairs and marketing have directed both the generation and dissemination of information about their…